Drug Search Results
More Filters [+]

MT-4129

Alternative Names: mt-4129, mt4129, mt 4129
Latest Update: 2017-05-18
Latest Update Note: Clinical Trial Update

Product Description

MT-4129 is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension

Mechanisms of Action: Aldosterone Synthase Inhibitor

Novel Mechanism: Yes

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Mitsubishi Tanabe
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MT-4129

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MT-4129-E01

P1

Completed

Healthy Volunteers

2017-05-01

Recent News Events

Date

Type

Title